WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MGNX past revenue growth

How has MGNX's revenue growth performed historically?
Company
-73.1%
Industry
74%
Market
16.91%
MGNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MGNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MGNX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MGNX earnings and revenue history

Current Revenue
$41.0M
Current Earnings
-$136.4M
Current Profit Margin
-332.5%

MGNX Return on Equity

Current Company
-106.8%
Current Industry
22.9%
Current Market
33.8%
MGNX's Return on Equity (-106.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MGNX announces earnings.

MGNX Return on Assets

Current Company
-50.1%
Current Industry
3.5%
MGNX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MGNX Return on Capital Employed

Current Company
-94.42%
Current Industry
21.4%
MGNX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MGNX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MGNX$41.02M-$124.85M-$136.37M-6.32%N/A
CLLS$19.64M-$30.80M-$79.97M+11.54%N/A
ZURA$0.00-$34.82M-$27.94MN/AN/A
PYXS$16.15M-$55.61M-$59.20MN/AN/A
RIGL$130.30M-$4.93M-$14.23M+14.66%N/A
View Top Biotech Stocks

MGNX earnings dates

Next earnings date
Nov 4, 2024

Macrogenics Earnings & Revenue FAQ

What were MGNX's earnings last quarter?

On Invalid Date, Macrogenics (NASDAQ: MGNX) reported Q2 2024 earnings per share (EPS) of -$0.89, up 195.7% year over year. Total Macrogenics earnings for the quarter were -$55.66 million. In the same quarter last year, Macrogenics's earnings per share (EPS) was $0.93.

If you're new to stock investing, here's how to buy Macrogenics stock.

What was MGNX's earnings growth in the past year?

As of Q3 2024, Macrogenics's earnings has grown year over year. Macrogenics's earnings in the past year totalled -$136.37 million.

What is MGNX's earnings date?

Macrogenics's earnings date is Invalid Date. Add MGNX to your watchlist to be reminded of MGNX's next earnings announcement.

What was MGNX's revenue last quarter?

On Invalid Date, Macrogenics (NASDAQ: MGNX) reported Q2 2024 revenue of $10.80 million up 17.81% year over year. In the same quarter last year, Macrogenics's revenue was $13.14 million.

What was MGNX's revenue growth in the past year?

As of Q3 2024, Macrogenics's revenue has grown -73.1% year over year. This is 147.09 percentage points lower than the US Biotechnology industry revenue growth rate of 74%. Macrogenics's revenue in the past year totalled $41.02 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.